| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article; Research Support, Non-U.S. Gov't
- Language: English
- [J Cell Physiol] 2021 May; Vol. 236 (5), pp. 3565-3578. <i>Date of Electronic Publication: </i>2020 Oct 12.
- MeSH Terms: Antidepressive Agents / *metabolism ; Dentate Gyrus / *metabolism ; Galanin / *metabolism ; Neural Stem Cells / *metabolism ; Neuropeptide Y / *metabolism ; Animals ; Behavior, Animal ; Bromodeoxyuridine / metabolism ; Cell Membrane / metabolism ; Cell Proliferation ; Cells, Cultured ; Doublecortin Domain Proteins ; Doublecortin Protein ; Endocytosis ; MAP Kinase Signaling System ; Male ; Microtubule-Associated Proteins / metabolism ; Neuropeptides / metabolism ; Rats, Sprague-Dawley ; Receptor, Galanin, Type 2 / metabolism ; Receptors, Neuropeptide Y / agonists ; Receptors, Neuropeptide Y / metabolism ; Serum Response Element / genetics ; Swimming ; Rats
- References: Abbosh, C., Lawkowski, A., Zaben, M., & Gray, W. (2011). GalR2/3 mediates proliferative and trophic effects of galanin on postnatal hippocampal precursors. Journal of Neurochemistry, 117(3), 425-436. https://doi.org/10.1111/j.1471-4159.2011.07204.x. ; Abrial, E., Betourne, A., Etievant, A., Lucas, G., Scarna, H., Lambas-Senas, L., & Haddjeri, N. (2014). Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania. International Journal of Neuropsychopharmacology, 18(2):pyu031. https://doi.org/10.1093/ijnp/pyu031. ; Baptista, P., & Andrade, J. P. (2018). Adult hippocampal neurogenesis: Regulation and possible functional and clinical correlates. Frontiers in Neuroanatomy, 12, 44. https://doi.org/10.3389/fnana.2018.00044. ; Bauman, M. D., Schumann, C. M., Carlson, E. L., Taylor, S. L., Vazquez-Rosa, E., Cintron-Perez, C. J., & Pieper, A. A. (2018). Neuroprotective efficacy of P7C3 compounds in primate hippocampus. Translational Psychiatry, 8(1):202. https://doi.org/10.1038/s41398-018-0244-1. ; Boldrini, M., Fulmore, C. A., Tartt, A. N., Simeon, L. R., Pavlova, I., Poposka, V., & Mann, J. J. (2018). Human hippocampal neurogenesis persists throughout aging. Cell Stem Cell, 22(4), 589-599 e585. https://doi.org/10.1016/j.stem.2018.03.015. ; Borroto-Escuela, D. O., Hagman, B., Woolfenden, M., Pinton, L., Jiménez-Beristain, A., & Oflijan, J., et al (2016). In situ proximity ligation assay to study and understand the distribution and balance of GPCR homo- and heteroreceptor complexes in the brain. In R. Lujan, & F. Ciruela (Eds.), Receptor and ion channel detection in the brain (Vol. 110, pp. 109-126). Springer. ; Borroto-Escuela, D. O., Li, X., Tarakanov, A. O., Savelli, D., Narvaez, M., Shumilov, K., & Fuxe, K. (2017). Existence of brain 5-HT1A-5-HT2A isoreceptor complexes with antagonistic allosteric receptor-receptor interactions regulating 5-HT1A receptor recognition. ACS Omega, 2(8), 4779-4789. https://doi.org/10.1021/acsomega.7b00629. ; Borroto-Escuela, D. O., Narvaez, M., Marcellino, D., Parrado, C., Narvaez, J. A., Tarakanov, A. O., & Fuxe, K. (2010). Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization. Biochemical and Biophysical Research Communications, 393(4), 767-772. https://doi.org/10.1016/j.bbrc.2010.02.078. ; Borroto-Escuela, D. O., Narvaez, M., Di Palma, M., Calvo, F., Rodriguez, D., Millon, C., & Fuxe, K. (2014). Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex. Biochemical and Biophysical Research Communications, 452(3), 347-353. https://doi.org/10.1016/j.bbrc.2014.08.061. ; Borroto-Escuela, D. O., Romero-Fernandez, W., Mudo, G., Perez-Alea, M., Ciruela, F., Tarakanov, A. O., & Fuxe, K. (2012). Fibroblast growth factor receptor 1- 5-hydroxytryptamine 1A heteroreceptor complexes and their enhancement of hippocampal plasticity. Biological Psychiatry, 71(1), 84-91. https://doi.org/10.1016/j.biopsych.2011.09.012. ; Branchek, T. A., Smith, K. E., Gerald, C., & Walker, M. W. (2000). Galanin receptor subtypes. Trends In Pharmacological Sciences, 21(3), 109-117. https://doi.org/10.1016/s0165-6147(00)01446-2. ; Catena-Dell'Osso, M., Fagiolini, A., Marazziti, D., Baroni, S., & Bellantuono, C. (2013). Non-monoaminergic targets for the development of antidepressants: Focus on neuropeptides. Mini Reviews in Medicinal Chemistry, 13(1), 2-10. ; Chen, P. (2019). Optimized treatment strategy for depressive disorder. Advances in Experimental Medicine and Biology, 1180, 201-217. https://doi.org/10.1007/978-981-32-9271-0_11. ; Cheung, A., Newland, P. L., Zaben, M., Attard, G. S., & Gray, W. P. (2012). Intracellular nitric oxide mediates neuroproliferative effect of neuropeptide y on postnatal hippocampal precursor cells. Journal of Biological Chemistry, 287(24), 20187-20196. https://doi.org/10.1074/jbc.M112.346783. ; Cipriani, S., Ferrer, I., Aronica, E., Kovacs, G. G., Verney, C., Nardelli, J., & Adle-Biassette, H. (2018). Hippocampal radial glial subtypes and their neurogenic potential in human fetuses and healthy and Alzheimer's disease adults. Cerebral Cortex, 28(7), 2458-2478. https://doi.org/10.1093/cercor/bhy096. ; Decressac, M., Wright, B., David, B., Tyers, P., Jaber, M., Barker, R. A., & Gaillard, A. (2011). Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis. Hippocampus, 21(3), 233-238. https://doi.org/10.1002/hipo.20765. ; Diaz-Cabiale, Z., Parrado, C., Narvaez, M., Puigcerver, A., Millon, C., Santin, L., & Narvaez, J. A. (2011). Galanin receptor/neuropeptide Y receptor interactions in the dorsal raphe nucleus of the rat. Neuropharmacology, 61(1-2), 80-86. https://doi.org/10.1016/j.neuropharm.2011.03.002. ; DiazGranados, N., Ibrahim, L. A., Brutsche, N. E., Ameli, R., Henter, I. D., Luckenbaugh, D. A., & Zarate, C. A., Jr. (2010). Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. Journal of Clinical Psychiatry, 71(12), 1605-1611. https://doi.org/10.4088/JCP.09m05327blu. ; Eriksson, P. S., Perfilieva, E., Bjork-Eriksson, T., Alborn, A. M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998). Neurogenesis in the adult human hippocampus. Nature Medicine, 4(11), 1313-1317. https://doi.org/10.1038/3305. ; Fanselow, M. S., & Dong, H. W. (2010). Are the dorsal and ventral hippocampus functionally distinct structures? Neuron, 65(1), 7-19. https://doi.org/10.1016/j.neuron.2009.11.031. ; Fuxe, K., Agnati, L., Aguirre, J., Bjelke, B., Tinner, B., Merlo-Pich, E., & Eneroth, P. (1991). On the existence of volume transmission in the central neuropeptide Y neuronal systems. Studies on transmitter receptor mismatches and on biological effects of neuropeptide Y fragments. In K. Fuxe, & L. F. Agnati (Eds.), Advances in neuroscience, volume transmission in the brain, novel mechanisms for neural transmission (pp. 105-130). Raven Press, Ltd. ; Fuxe, K., & Borroto-Escuela, D. O. (2018). Receptor-receptor interactions in the central nervous system (Vol. 140, p. 346). Humana Press. ; Gehlert, D. R., Schober, D. A., Morin, M., & Berglund, M. M. (2007). Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties. Biochemical Pharmacology, 74(11), 1652-1664. https://doi.org/10.1016/j.bcp.2007.08.017. ; Geloso, M. C., Corvino, V., Di Maria, V., Marchese, E., & Michetti, F. (2015). Cellular targets for neuropeptide Y-mediated control of adult neurogenesis. Frontiers in Cellular Neuroscience, 9, 85. https://doi.org/10.3389/fncel.2015.00085. ; Gigliucci, V., O'Dowd, G., Casey, S., Egan, D., Gibney, S., & Harkin, A. (2013). Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism. Psychopharmacology, 228(1), 157-166. https://doi.org/10.1007/s00213-013-3024-x. ; Harmer, C. J., Duman, R. S., & Cowen, P. J. (2017). How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry, 4(5), 409-418. https://doi.org/10.1016/S2215-0366(17)30015-9. ; Howell, O. W., Scharfman, H. E., Herzog, H., Sundstrom, L. E., Beck-Sickinger, A., & Gray, W. P. (2003). Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells. Journal of Neurochemistry, 86(3), 646-659. https://doi.org/10.1046/j.1471-4159.2003.01895.x. ; Howell, O. W., Silva, S., Scharfman, H. E., Sosunov, A. A., Zaben, M., Shtaya, A., & Gray, W. P. (2007). Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus. Neurobiology of Disease, 26(1), 174-188. https://doi.org/10.1016/j.nbd.2006.12.014. ; Jimenez-Vasquez, P. A., Diaz-Cabiale, Z., Caberlotto, L., Bellido, I., Overstreet, D., Fuxe, K., & Mathe, A. A. (2007). Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression. European Neuropsychopharmacology, 17(4), 298-308. https://doi.org/10.1016/j.euroneuro.2006.06.011. ; Kempermann, G., Gage, F. H., Aigner, L., Song, H., Curtis, M. A., Thuret, S., & Frisen, J. (2018). Human adult neurogenesis: Evidence and remaining questions. Cell Stem Cell, 23(1), 25-30. https://doi.org/10.1016/j.stem.2018.04.004. ; Kempermann, G., Song, H., & Gage, F. H. (2015). Neurogenesis in the adult hippocampus. Cold Spring Harbor Perspectives in Biology, 7(9):a018812. https://doi.org/10.1101/cshperspect.a018812. ; Koike, H., & Chaki, S. (2014). Requirement of AMPA receptor stimulation for the sustained antidepressant activity of Ketamine and LY341495 during the forced swim test in rats. Behavioural Brain Research, 271, 111-115. https://doi.org/10.1016/j.bbr.2014.05.065. ; Kormos, V., & Gaszner, B. (2013). Role of neuropeptides in anxiety, stress, and depression: from animals to humans. Neuropeptides, 47(6), 401-419. https://doi.org/10.1016/j.npep.2013.10.014. ; Kotagale, N. R., Paliwal, N. P., Aglawe, M. M., Umekar, M. J., & Taksande, B. G. (2013). Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats. Peptides, 47, 7-11. https://doi.org/10.1016/j.peptides.2013.04.018. ; Kuteeva, E., Wardi, T., Lundstrom, L., Sollenberg, U., Langel, U., Hokfelt, T., & Ogren, S. O. (2008). Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level. Neuropsychopharmacology, 33(11), 2573-2585. https://doi.org/10.1038/sj.npp.1301660. ; Li, B. S., Ma, W., Zhang, L., Barker, J. L., Stenger, D. A., & Pant, H. C. (2001). Activation of phosphatidylinositol-3 kinase (PI-3K) and extracellular regulated kinases (Erk1/2) is involved in muscarinic receptor-mediated DNA synthesis in neural progenitor cells. Journal of Neuroscience, 21(5), 1569-1579. ; Lu, X., Ross, B., Sanchez-Alavez, M., Zorrilla, E. P., & Bartfai, T. (2008). Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests. Neuropeptides, 42(4), 387-397. https://doi.org/10.1016/j.npep.2008.04.009. ; Luo, H., Liu, Z., Liu, B., Li, H., Yang, Y., & Xu, Z. D. (2019). Virus-mediated overexpression of ETS-1 in the ventral hippocampus counteracts depression-like behaviors in rats. Neuroscience Bulletin, 35(6), 1035-1044. https://doi.org/10.1007/s12264-019-00412-6. ; Mathe, A. A., Jimenez, P. A., Theodorsson, E., & Stenfors, C. (1998). Neuropeptide Y, neurokinin A and neurotensin in brain regions of Fawn Hooded "depressed", Wistar, and Sprague Dawley rats. Effects of electroconvulsive stimuli. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 22(3), 529-546. https://doi.org/10.1016/s0278-5846(98)00023-2. ; McKay, M. M., & Morrison, D. K. (2007). Integrating signals from RTKs to ERK/MAPK. Oncogene, 26(22), 3113-3121. https://doi.org/10.1038/sj.onc.1210394. ; Miller, B. R., & Hen, R. (2015). The current state of the neurogenic theory of depression and anxiety. Current Opinion in Neurobiology, 30, 51-58. https://doi.org/10.1016/j.conb.2014.08.012. ; Moreno-Jimenez, E. P., Flor-Garcia, M., Terreros-Roncal, J., Rabano, A., Cafini, F., Pallas-Bazarra, N., & Llorens-Martin, M. (2019). Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease. Nature Medicine, 25(4), 554-560. https://doi.org/10.1038/s41591-019-0375-9. ; Narvaez, M., Andrade-Talavera, Y., Valladolid-Acebes, I., Fredriksson, M., Siegele, P., Hernandez-Sosa, A., & Borroto-Escuela, D. O. (2020). Existence of FGFR1-5-HT1AR heteroreceptor complexes in hippocampal astrocytes. Putative link to 5-HT and FGF2 modulation of hippocampal gamma oscillations. Neuropharmacology, 170, 108070. https://doi.org/10.1016/j.neuropharm.2020.108070. ; Narvaez, M., Borroto-Escuela, D. O., Millon, C., Gago, B., Flores-Burgess, A., Santin, L., & Diaz-Cabiale, Z. (2016). Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the dentate gyrus are related with antidepressant-like effects. Brain Structure & Function, 221(8), 4129-4139. https://doi.org/10.1007/s00429-015-1153-1. ; Narvaez, M., Borroto-Escuela, D. O., Santin, L., Millon, C., Gago, B., Flores-Burgess, A., & Fuxe, K. (2018). A novel integrative mechanism in anxiolytic behavior induced by galanin 2/neuropeptide Y Y1 receptor interactions on medial paracapsular intercalated amygdala in rats. Frontiers in Cellular Neuroscience, 12, 119. https://doi.org/10.3389/fncel.2018.00119. ; Narvaez, M., Millon, C., Borroto-Escuela, D., Flores-Burgess, A., Santin, L., Parrado, C., & Diaz-Cabiale, Z. (2015). Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions. Brain Structure & Function, 220(4), 2289-2301. https://doi.org/10.1007/s00429-014-0788-7. ; O'Donnell, D., Ahmad, S., Wahlestedt, C., & Walker, P. (1999). Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. Journal of Comparative Neurology, 409(3), 469-481. ; Paxinos, G., & Watson, C. (1998). The Rat Brain in Stereotaxic Coordinates. 4th ed., Academic Press. ; Petit-Demouliere, B., Chenu, F., & Bourin, M. (2005). Forced swimming test in mice: A review of antidepressant activity. Psychopharmacology, 177(3), 245-255. https://doi.org/10.1007/s00213-004-2048-7. ; Pilar-Cuellar, F., Vidal, R., & Pazos, A. (2012). Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, beta-catenin, and antidepressant-like effects. British Journal of Pharmacology, 165(4b), 1046-1057. https://doi.org/10.1111/j.1476-5381.2011.01516.x. ; Porsolt, R. D., Le Pichon, M., & Jalfre, M. (1977). Depression: A new animal model sensitive to antidepressant treatments. Nature, 266(5604), 730-732. https://doi.org/10.1038/266730a0. ; Redrobe, J. P., Dumont, Y., Fournier, A., & Quirion, R. (2002). The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology, 26(5), 615-624. https://doi.org/10.1016/S0893-133X(01)00403-1. ; Sorrells, S. F., Paredes, M. F., Cebrian-Silla, A., Sandoval, K., Qi, D., Kelley, K. W., & Alvarez-Buylla, A. (2018). Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature, 555(7696), 377-381. https://doi.org/10.1038/nature25975. ; Spalding, K. L., Bergmann, O., Alkass, K., Bernard, S., Salehpour, M., Huttner, H. B., & Frisen, J. (2013). Dynamics of hippocampal neurogenesis in adult humans. Cell, 153(6), 1219-1227. https://doi.org/10.1016/j.cell.2013.05.002. ; Sperk, G., Hamilton, T., & Colmers, W. F. (2007). Neuropeptide Y in the dentate gyrus. Progress in Brain Research, 163, 285-297. https://doi.org/10.1016/S0079-6123(07)63017-9. ; Tanti, A., & Belzung, C. (2013). Neurogenesis along the septo-temporal axis of the hippocampus: are depression and the action of antidepressants region-specific? Neuroscience, 252, 234-252. https://doi.org/10.1016/j.neuroscience.2013.08.017. ; Vega-Rivera, N. M., Fernandez-Guasti, A., Ramirez-Rodriguez, G., & Estrada-Camarena, E. (2015). Effect of sub-optimal doses of fluoxetine plus estradiol on antidepressant-like behavior and hippocampal neurogenesis in ovariectomized rats. Psychoneuroendocrinology, 57, 113-124. https://doi.org/10.1016/j.psyneuen.2015.03.022. ; Walker, A. K., Rivera, P. D., Wang, Q., Chuang, J. C., Tran, S., Osborne-Lawrence, S., & Zigman, J. M. (2015). The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis. Molecular Psychiatry, 20(4), 500-508. https://doi.org/10.1038/mp.2014.34. ; World Health Organization. (2017). Depression and other common mental disorders: global health estimates. World Health Organization. ; Xia, S., Kjaer, S., Zheng, K., Hu, P. S., Xu, T., Hokfelt, T., & Xu, Z. Q. (2005). Constitutive and ligand-induced internalization of EGFP-tagged galanin R2 and Rl receptors in PC12 cells. Neuropeptides, 39(3), 173-178. https://doi.org/10.1016/j.npep.2005.02.001. ; Zaben, M. J., & Gray, W. P. (2013). Neuropeptides and hippocampal neurogenesis. Neuropeptides, 47(6), 431-438. https://doi.org/10.1016/j.npep.2013.10.002.
- Contributed Indexing: Keywords: Depression; Galanin; Neuropeptide Y; Neuropeptides; Receptor interaction
- Substance Nomenclature: 0 (Antidepressive Agents) ; 0 (Dcx protein, rat) ; 0 (Doublecortin Domain Proteins) ; 0 (Doublecortin Protein) ; 0 (Microtubule-Associated Proteins) ; 0 (Neuropeptide Y) ; 0 (Neuropeptides) ; 0 (Receptor, Galanin, Type 2) ; 0 (Receptors, Neuropeptide Y) ; 0 (neuropeptide Y-Y1 receptor) ; 88813-36-9 (Galanin) ; G34N38R2N1 (Bromodeoxyuridine)
- Entry Date(s): Date Created: 20201012 Date Completed: 20210929 Latest Revision: 20240226
- Update Code: 20240226
|
